Khiron Life Sciences Corp.
KHRNF · OTC
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Market Cap | $34 | $45 | $107 | $74 |
| - Cash | $9 | $22 | $9 | $15 |
| + Debt | $2 | $3 | $4 | $3 |
| Enterprise Value | $28 | $27 | $101 | $61 |
| Revenue | $13 | $8 | $10 | $1 |
| % Growth | 59.6% | -16.3% | 974.6% | – |
| Gross Profit | $6 | $7 | $2 | $0 |
| % Margin | 49.8% | 87.4% | 25.4% | 33.3% |
| EBITDA | -$32 | -$23 | -$36 | -$18 |
| % Margin | -250.4% | -285.1% | -380.8% | -2,050.9% |
| Net Income | -$33 | -$24 | -$36 | -$20 |
| % Margin | -258.9% | -299.8% | -379.6% | -2,221.3% |
| EPS Diluted | -0.2 | -0.2 | -0.36 | -0.41 |
| % Growth | 0% | 44.4% | 12.2% | – |
| Operating Cash Flow | -$20 | -$25 | -$30 | -$15 |
| Capital Expenditures | -$2 | -$3 | -$6 | -$4 |
| Free Cash Flow | -$22 | -$27 | -$36 | -$19 |